Skip to main content
  • Contact Us
  • Vantage logo Sign Up
  • Subscriber Sign In
Evaluate Logo

navigation

  • What We Do
    • Commercial Intelligence
    • Products
      • Evaluate Pharma
      • Evaluate Omnium
      • Evaluate Medtech
      • Evaluate Epi
      • Japan Drug Forecasts
      • Europe Drug Forecasts
    • Pharma Consulting & Analytics
      • Pharma Consulting & Analytics
      • Data Feeds
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Insights
      • Events
      • Medtech
      • Therapy Areas
      • Editorial Team
      • About Evaluate Vantage
    • Evaluate for Biotech
  • How We Can Help You
    • Pharma and Biotech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
    • Multimedia
    • Blog
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Talent
  • Subscriber Sign In

 

Vantage logo

Vantage

  • Covid-19
    • Covid-19 Coverage
    • Evaluate Vantage COVID-19 Report
  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas
  • About
    • Editorial team

Breadcrumb

  1. Home
  2. Vantage
  3. Pharmaceutical Companies
  4. Laboratory Corporation America

Evaluate

Thumbnail
May 09, 2023

Baxter finds a $4.3bn biopharma solution

Thumbnail
February 14, 2022

Covid test revenues to crash in 2022

Article image
Vantage logo
December 31, 2021

Medtech developments over the Christmas period

The FDA scrambles for more rapid Covid-19 tests, and the device sector enjoys a late flurry of deals.

Article image
Vantage logo
June 08, 2021

Aduhelm approval amplifies amyloid assays

Biogen needs blood tests for amyloid beta to progress quickly – and several are in the pipeline.

Article image
Vantage logo
December 14, 2020

There’s no place like home for Covid-19 testing

Article image
Vantage logo
November 16, 2020

A lull in FDA Covid-19 test authorisations

Just as demand for coronavirus tests is peaking, the US regulator has a quiet week.

Article image
Vantage logo
September 14, 2020

More pooled Covid-19 testing as labs struggle to meet demand

Article image
Vantage logo
July 27, 2020

LabCorp to spearhead new Covid-19 screening technique

Article image
Vantage logo
May 18, 2020

At-home Covid-19 testing takes another leap

Article image
Vantage logo
March 20, 2020

Genmark adds $100m in value on Covid-19 test authorisation

Article image
Vantage logo
March 17, 2020

Two more test nods as FDA relaxes rules still further

  • Load More
Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up

Latest Reports

May 15, 2023

Pharma’s Biggest Spenders 2022 Infographic

May 03, 2023

Gene Editing: Overhyped or Unstoppable Tide?

View more...

Editor's Picks

Vantage logo
May 16, 2023

Heightened US antitrust fears rattle biopharma

Vantage logo
May 11, 2023

2023’s biggest launches: the story so far

Vantage logo
May 17, 2023

Viking’s Voyage is not over yet

Vantage logo
May 09, 2023

Gene editing: overhyped or unstoppable tide?

Vantage logo
May 16, 2023

A slow (and low) year for FDA approvals

Open modal

Evaluate Logo

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-80-1164-4754

Footer menu

  • Terms and conditions
  • Privacy Policies
  • Cookie Policy
  • Modern Slavery Statement

© Copyright 2023 Evaluate Ltd.

Sign up